Yatharth Hospital & Trauma Care Services Ltd
NSE: YATHARTHBSE: 543950
₹ 944.00▼ 9.7 (−1.02%)28 Oct, 03:29 pm IST
- P/E
- 50.3x
- 52-week range
- 538.25 – 1,184
- ROE
- 10%
- ROCE
- 12%
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Yatharth Hospital & Trauma Care Services Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)50.3 against a typical 48.9: pricier than most peers (1st = cheapest).21st of 40
- Sales growth+52.3% against a typical +21.1% from a year earlier.7th of 34
- Profit growth+7.1% against a typical +13% from a year earlier.18th of 31
- Share price, 3 months+13.3% against a typical −10.9%.6th of 34
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A by CRISILA
DefaultRiskyModerateSafeVery safe
- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil A | Stable | 28 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 28 Sep 2026 | Reaffirmed | Crisil A | — | CRISIL | — | |
| 20 May 2026 | Reaffirmed | Crisil A | — | CRISIL | — | |
| 6 Nov 2025 | ▲ Upgrade1 notch | CRISIL A- → Crisil A | — | CRISIL | — | |
| 23 Sep 2025 | Rating action | CRISIL A- | — | CRISIL | — |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 3 Nov 2026Upcoming | Financial Results | To consider and approve the Unaudited Financial Results for Q2FY27. |
| 17 Sep 2026 | Fund Raising | To consider Fund raising by way of Issuance of equity shares or other securities. |
| 10 Aug 2026 | Financial Results/Dividend/Other business matters | To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the period ended Jun 30, 2026, dividend and other business matters. |
| 25 May 2026 | Financial Results | To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended on March 31, 2026. |
| 5 Feb 2026 | Financial Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2025 |
| 13 Nov 2025 | Financial Results | To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the second quarter and half year ended September 30, 2025. |
| 5 Aug 2025 | Financial Results | To consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 171 | 167 | 178 | 212 | 218 | 219 | 232 | 258 | 279 | 320 | 342 | 393 |
| Expenses | 126 | 120 | 131 | 158 | 163 | 164 | 175 | 193 | 215 | 246 | 262 | 301 |
| Operating Profit | 46 | 46 | 47 | 54 | 55 | 55 | 57 | 64 | 65 | 74 | 80 | 92 |
| OPM % | 27% | 28% | 26% | 25% | 25% | 25% | 25% | 25% | 23% | 23% | 23% | 23% |
| Other Income | 4 | 5 | 6 | 4 | 3 | 4 | 5 | 9 | 9 | 8 | 7 | 4 |
| Interest | 3 | 0 | 0 | 3 | 2 | 2 | 1 | 0 | 0 | 1 | 5 | 7 |
| Depreciation | 7 | 8 | 8 | 11 | 16 | 17 | 13 | 15 | 19 | 24 | 30 | 28 |
| Profit before tax | 40 | 44 | 44 | 43 | 40 | 40 | 49 | 59 | 55 | 57 | 52 | 61 |
| Tax % | 30% | 33% | 13% | 29% | 23% | 24% | 20% | 28% | 25% | 25% | 14% | 26% |
| Net Profit | 28 | 29 | 38 | 30 | 31 | 30 | 39 | 42 | 41 | 43 | 45 | 45 |
| EPS in Rs | 3.21 | 3.44 | 4.47 | 3.54 | 3.61 | 3.16 | 4.02 | 4.36 | 4.28 | 4.71 | 4.93 | 4.88 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- 41%
- 3 Years
- 36%
- TTM
- 44%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- 57%
- 3 Years
- 39%
- TTM
- 27%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 31%
- TTM
- —
Return on Equity
- 10 Years
- 14%
- 5 Years
- 14%
- 3 Years
- 12%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 50.3xEPS (12 months) ₹ 18.80Median P/E 43.4x
P/E (times)EPS (₹)
Prices are delayed and for information only. Nothing on this page is investment advice.